New RNA vaccines show promise in small COVID-19 study
NCT ID NCT05037097
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 35 times
Summary
This study tested three new self-amplifying RNA vaccines against COVID-19 in 72 healthy adults, including some who had already been vaccinated and some who had not. The main goals were to check safety and measure the immune response. The vaccines were designed to help the body fight the virus, including newer variants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arcturus Investigational Site 101
Singapore, 169608, Singapore
-
Arcturus Investigational Site 201
Kansas City, Missouri, 64114, United States
-
Arcturus Investigational Site 202
Wichita, Kansas, 67207, United States
-
Arcturus Investigational Site 301
Diepkloof, Soweto, 1862, South Africa
Conditions
Explore the condition pages connected to this study.